European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

DOI

  • Carina Blomström-Lundqvist, Department of Medical Science and Cardiology, Uppsala University, Uppsala, Sweden.
  • ,
  • Vassil Traykov, Department of Invasive Electrophysiology and Cardiac Pacing, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria.
  • ,
  • Paola Anna Erba, Department of Translational Research and New Technology in Medicine, University of Pisa, AOUP, Italy and Department on Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • ,
  • Haran Burri, Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland.
  • ,
  • Jens Cosedis Nielsen
  • Maria Grazia Bongiorni, Cardiology and Arrhythmology Division, CardioThoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.
  • ,
  • Jeanne Poole, Cardiovascular Health Research Unit, Division of Cardiology, University of Washington, Seattle, WA, 98101, USA.
  • ,
  • Giuseppe Boriani, Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
  • ,
  • Roberto Costa, Department of Cardiovascular Surgery, Heart Institute (InCor) of the University of São Paulo, São Paulo, Brazil.
  • ,
  • Jean-Claude Deharo, Department of Cardiology, Aix Marseille Université, CHU la Timone, Marseille, France.
  • ,
  • Laurence M Epstein, System Director, Electrophysiology, Northwell Health, Hofstra/Northwell School of Medicine, Manhasset, NY, USA.
  • ,
  • Laszlo Saghy, Electrophysiology Division, 2nd Department of Medicine and Cardiology Centre, University of Szeged, Szeged, Hungary.
  • ,
  • Ulrika Snygg-Martin, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • ,
  • Christoph Starck, Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
  • ,
  • Carlo Tascini, First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli, Naples, Italy.
  • ,
  • Neil Strathmore, APHRS Reviewer, Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.
  • ,
  • ESC Scientific Document Group

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.

Original languageEnglish
JournalEuropean Journal of Cardio-Thoracic Surgery
Volume57
Issue1
Pages (from-to)e1-e31
Number of pages31
ISSN1010-7940
DOIs
Publication statusPublished - 2020

    Research areas

  • ANTIBIOTIC-PROPHYLAXIS, CARDIOVERTER-DEFIBRILLATOR IMPLANTATION, Cardiac implantable electronic devices, Cardiac resynchronization therapy, EHRA consensus document, Endocarditis, Extraction, F-18-FDG PET/CT, Implantable cardioverter-defibrillators, Infection, LONG-TERM COMPLICATIONS, Leads, Microbiology, PERMANENT PACEMAKER IMPLANTATION, Pacemakers, RISK-FACTORS, Re-implantation, SINGLE-CENTER EXPERIENCE, STAPHYLOCOCCUS-AUREUS BACTEREMIA, SURGICAL-SITE, TRANSVENOUS LEAD EXTRACTION

See relations at Aarhus University Citationformats

ID: 174167770